Insider · CIK 0001795902
An van Es-Johansson
director
Files at CNSY (CERENOME, INC.), LUMOS PHARMA, INC., SVRA (Savara Inc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | CNSY CERENOME, INC. | MOption exercise Common Stock | +921 | $0.00 | $0 | 1,843 | 11 d ago |
| Oct 1, 2026 | CNSY CERENOME, INC. | MOption exercise Restricted Stock Unitsderivative | -921 | $0.00 | $0 | 1,843 | 11 d ago |
| Dec 12, 2024 | SVRA Savara Inc | AGrant or award Common Stock | +40,000 | $0.00 | $0 | 62,500 | Dec 16, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Common Stock | -1,100 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,345 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,328 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,431 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -2,910 | - | - | 0 | Dec 13, 2024 |
| Dec 12, 2024 | - LUMOS PHARMA, INC. | DDisposition to issuer Stock Option (Right to Buy)derivative | -5,729 | - | - | 0 | Dec 13, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.